98%
921
2 minutes
20
Background: Cardiovascular disease (CVD) remains the leading cause of mortality worldwide, emphasizing the need for enhanced risk stratification tools. The triglyceride‒glucose-weight adjusted waist index (TyG-WWI), which integrates insulin resistance and central obesity, has emerged as a potential predictor, but its performance relative to traditional TyG-related indices (TyG, TyG-WC, TyG-WHtR) requires further validation.
Methods: We analyzed data from 24,255 participants in the National Health and Nutrition Examination Survey (NHANES, 1999-2018). Weighted Cox proportional hazards models were used to assess the associations between TyG-related indices and cardiovascular mortality. Restricted cubic splines (RCSs) with four knots were employed to explore dose‒response relationships. Traditional and time-dependent receiver operating characteristic (ROC) analyses, net reclassification improvement (NRI) analyses, and subgroup and sensitivity analyses were conducted to evaluate predictive performance and robustness.
Results: Over a median follow-up of 9.67 years, 854 cardiovascular deaths were recorded. According to the fully adjusted models, each increase in the standard deviation of the TyG-WWI was associated with a 45% greater risk of cardiovascular mortality (HR = 1.45, 95% CI 1.31-1.60), which was stronger than the associations observed for TyG (HR = 1.24, 95% CI 1.12-1.38), TyG-WC (HR = 1.39, 95% CI 1.27-1.53), and TyG-WHtR (HR = 1.43, 95% CI 1.30-1.58). When stratified by quartiles, the TyG-WWI exhibited a clear dose‒response relationship. RCS analyses revealed that the TyG-WWI had a linear association with cardiovascular mortality (P-nonlinear = 0.491), whereas the TyG index exhibited a U-shaped association, and the TyG-WC index and TyG-WHtR showed L-shaped associations (all P-nonlinear < 0.05). Traditional ROC analysis revealed that the TyG-WWI had the highest AUC (0.694, 95% CI 0.678-0.710). Time-dependent ROC analyses demonstrated that the AUC for the TyG-WWI ranged from 0.706 to 0.751 across different follow-up time points, which was consistently greater than those of the other TyG-related indices. NRI analyses indicated significant improvements in risk reclassification when the TyG-WWI was used compared with traditional TyG-related indices (10.4% vs. TyG, 9.4% vs. TyG-WC, 9.1% vs. TyG-WHtR). Subgroup analyses revealed stronger associations in younger adults (≤ 60 years, HR = 2.03, 95% CI 1.78-2.32).
Conclusion: The current study is the first to validate that the TyG-WWI is a reliable risk prediction tool for cardiovascular death in the general population and has greater predictive value than traditional TyG-related parameters. The results support its potential as a supplementary tool among TyG-derived markers for assessing cardiovascular death.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12312566 | PMC |
http://dx.doi.org/10.1186/s12933-025-02873-8 | DOI Listing |
Ren Fail
December 2025
Department of Nephrology, Kidney Disease Medical Center, Tianjin Medical University General Hospital, National Key Clinical Specialty, Tianjin Key Medical Discipline, Tianjin, China.
Purpose: This study aimed to investigate the association between body roundness index (BRI) and deaths from all causes and cardiovascular disease (CVD) in participants with chronic kidney disease (CKD).
Materials And Methods: The data was sourced from the National Health and Nutrition Examination Survey (NHANES) 1999-2018. Cox proportional hazards regression along with restricted cubic splines were applied to assess the associations of BRI with deaths from all causes and CVD in individuals with CKD.
Ren Fail
December 2025
Renal Division, Department of Medicine, Peking University First Hospital, Peking University Institute of Nephrology, Beijing, China.
The Grams model, designed to predict adverse event risks in advanced chronic kidney disease (CKD) patients, was evaluated in a Chinese cohort of 1,333 patients with eGFR below 30 mL/min/1.73 m. The model demonstrated moderate to good discrimination across outcomes, performing well in predicting kidney replacement therapy (KRT) but overestimating the risks of cardiovascular disease (CVD) and mortality.
View Article and Find Full Text PDFAnaesthesiologie
September 2025
Klinik für Anästhesiologie, Universitätsklinikum Düsseldorf, Heinrich-Heine-Universität, Moorenstr. 5, 40225, Düsseldorf, Deutschland.
Sodium-glucose Cotransporter 2 (SGLT-2) inhibitors are oral antidiabetic drugs that were developed for the treatment of patients with diabetes mellitus and are now also approved for treating chronic heart failure and chronic kidney disease. By inhibiting SGLT‑2 in the proximal renal tubule, urinary excretion of glucose is increased. Large randomized trials have demonstrated improved glycemic control, reduced cardiovascular events and lower mortality but also an increased risk of urogenital infections and dehydration.
View Article and Find Full Text PDFCardiovasc Revasc Med
September 2025
Division of Vascular Surgery, Cardiovascular Center, Tufts Medical Center, Boston, MA, USA; Tufts University School of Medicine, Boston, MA, USA. Electronic address:
Background: protamine sulfate is used to reduce bleeding risk after Carotid Artery Stenting (CAS), but its efficacy in personalized patient settings remains underexplored. This study aims to identify factors associated with greater benefits from protamine sulfate following CAS.
Methods: A retrospective review of Vascular Quality Initiative (VQI) data (2016-2022) identified patients undergoing CAS, divided into Transfemoral CAS (TF-CAS) and Transcarotid artery revascularization (TCAR) groups.
Acad Radiol
September 2025
Department of Nuclear Medicine, National Taiwan University Hospital, Taipei, Taiwan (J.Y.H., C.L.K., K.L.C.); College of Medicine, National Taiwan University, Taipei, Taiwan (J.Y.H., C.K.H., K.L.C., Y.W.W.); Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan (C.K
Rationale And Objectives: The prognostic implications of myocardial perfusion imaging (MPI) are imperative to provide proper management of coronary artery disease (CAD). This study aimed to quantify the long-term prognostic value of MPI under routine clinical conditions.
Materials And Methods: This single-center retrospective cohort study evaluated all-cause mortality and cause-specific survival according to MPI findings in patients with suspected or known CAD who underwent diagnostic evaluation or assessment of myocardial ischemia and viability in a tertiary referral cardiovascular center.